Recruiting
|

A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA

Enter your postal code
to see sites near you
Recruiting
|

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Enter your postal code
to see sites near you
Recruiting
|

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3471851 in Participants With Psoriasis

Enter your postal code
to see sites near you
Recruiting
|

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Enter your postal code
to see sites near you
Recruiting
|

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study of Donanemab (LY3002813) in Participants with Early Alzheimer’s Disease (TRAILBLAZER-ALZ 2)

Enter your postal code
to see sites near you
Recruiting
|

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)

Enter your postal code
to see sites near you
Recruiting
|

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain

Enter your postal code
to see sites near you
Recruiting
|

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3502970 in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Recruiting
|

A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine

Enter your postal code
to see sites near you
Recruiting
|

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Enter your postal code
to see sites near you
Recruiting
|

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Enter your postal code
to see sites near you
Recruiting
|

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

Enter your postal code
to see sites near you
Recruiting
|

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants with Osteoarthritis

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3471851 in Participants With Eczema

Enter your postal code
to see sites near you
Recruiting
|

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes.

Enter your postal code
to see sites near you
Recruiting
|

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3462817 in Participants With Rheumatoid Arthritis

Enter your postal code
to see sites near you
Recruiting
|

A Study of Tirzepatide in Overweight and Very Overweight Participants

Enter your postal code
to see sites near you
Recruiting
|

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis (Eczema)

Enter your postal code
to see sites near you
Recruiting
|

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis (ADore)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Recruiting
|

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) (ISLAND-SLE)

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3405105 in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3041658 in Adults With Hidradenitis Suppurativa

Enter your postal code
to see sites near you
Recruiting
|

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3493269 in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Recruiting
|

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3209590 in Participants With Type 1 Diabetes

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3561774 in Participants With Dyslipidemia.

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Enter your postal code
to see sites near you
Recruiting
|

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Enter your postal code
to see sites near you
Recruiting
|

A Study to Measure Food and Calorie Consumption in Very Overweight Participants Using Tirzepatide

Enter your postal code
to see sites near you
Recruiting
|

A Safety Study of LY3462817 in Participants With Psoriasis

Enter your postal code
to see sites near you
Recruiting
|

A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a CGRP Antagonist

Enter your postal code
to see sites near you
Recruiting
|

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Enter your postal code
to see sites near you
Recruiting
|

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff (BLAZE-2)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib in Participants With Rheumatoid Arthritis

Enter your postal code
to see sites near you
Recruiting
|

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)

Enter your postal code
to see sites near you
Recruiting
|

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2)

Enter your postal code
to see sites near you
Recruiting
|

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer ( EMBER )

Enter your postal code
to see sites near you
Recruiting
|

A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors

Enter your postal code
to see sites near you
Recruiting
|

A Study of LY3451838 in Participants With Migraine

Enter your postal code
to see sites near you
Recruiting
|

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (LUCENT-ACT)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program (SURMOUNT-3)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19) (BLAZE-5)

Enter your postal code
to see sites near you
Not yet recruiting
|

Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer (CYCLONE 1)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) ( INSTRUCT-UC )

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)

Enter your postal code
to see sites near you
Not yet recruiting
|

A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Enrolling by invitation
|

A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD5)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (REACH-2)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3023414 in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (Hair Loss)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Participants With EGFR Mutation-Positive Metastatic NSCLC

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3200882 in Participants With Solid Tumors

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis (Eczema) (BREEZE-AD3)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer (JUNIPER)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (nextMONARCH 1)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (ANNOUNCE-2)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

Enter your postal code
to see sites near you
Active not recruiting
|

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Enter your postal code
to see sites near you
Active not recruiting
|

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY2951742 in the Prevention of Chronic Migraine (REGAIN)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Enter your postal code
to see sites near you
Active not recruiting
|

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis (Eczema) Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable (BREEZE-AD4)

Enter your postal code
to see sites near you
Active not recruiting
|

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Solanezumab in Older Participants Who May be at Risk for Memory Loss (A4)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease (SERENITY)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer (monarchE)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer (monarcHER)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Galcanezumab (LY2951742) in Participants with Cluster Headache

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC or Transitional Cell Carcinoma of the Urothelium

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) in Combination With Other Therapies in Participants With Breast Cancer That Has Spread

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes (AWARD-PEDS)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Enter your postal code
to see sites near you
Active not recruiting
|

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Enter your postal code
to see sites near you
Active not recruiting
|

A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis (COAST-Y)

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

Enter your postal code
to see sites near you
Active not recruiting
|

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors (PACT)

Enter your postal code
to see sites near you
Completed
|

A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

Enter your postal code
to see sites near you
Completed
|

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Enter your postal code
to see sites near you
Completed
|

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Enter your postal code
to see sites near you
Completed
|

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2875358 in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD1)

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis (COAST-V)

Enter your postal code
to see sites near you
Completed
|

A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2951742 in the Prevention of Episodic Migraine (EVOLVE-2)

Enter your postal code
to see sites near you
Completed
|

An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants with Type 2 Diabetes Mellitus (VIVID)

Enter your postal code
to see sites near you
Completed
|

A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

Enter your postal code
to see sites near you
Completed
|

A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY3023414 and Necitumumab in Participants With Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Enter your postal code
to see sites near you
Completed
|

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD2)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

Enter your postal code
to see sites near you
Completed
|

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Enter your postal code
to see sites near you
Completed
|

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, Hepatocellular Carcinoma, or Glioblastoma

Enter your postal code
to see sites near you
Completed
|

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Enter your postal code
to see sites near you
Completed
|

A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Enter your postal code
to see sites near you
Completed
|

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Enter your postal code
to see sites near you
Completed
|

A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease

Enter your postal code
to see sites near you
Completed
|

A Study of LY2801653 in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)

Enter your postal code
to see sites near you
Completed
|

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus (Award-10)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2951742 in Participants With Chronic Cluster Headache

Enter your postal code
to see sites near you
Completed
|

A Study of Abemaciclib (LY2835219) Alone or in Combination with Other Agents in Participants with Previously Treated Pancreatic Ductal Adenocarcinoma

Enter your postal code
to see sites near you
Completed
|

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer (neoMONARCH)

Enter your postal code
to see sites near you
Completed
|

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes (T2DM)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Enter your postal code
to see sites near you
Completed
|

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

Enter your postal code
to see sites near you
Completed
|

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis (IXORA-P)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2606368 in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY3154207 in Participants With Parkinson's Disease (Part B)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2951742 in the Prevention of Episodic Migraine (EVOLVE-1)

Enter your postal code
to see sites near you
Completed
|

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Enter your postal code
to see sites near you
Completed
|

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY3209590 in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis (COAST-W)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3113593 in Participants With Chronic Kidney Disease

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis (IXORA-Q)

Enter your postal code
to see sites near you
Completed
|

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 in a Medtronic Pump

Enter your postal code
to see sites near you
Completed
|

A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis (Spirit-H2H)

Enter your postal code
to see sites near you
Completed
|

A Study of LY3202328 in Overweight Healthy Participants and in Participants With Dyslipidemia

Enter your postal code
to see sites near you
Completed
|

A Study of Tirzepatide in Participants With Impaired Liver Function

Enter your postal code
to see sites near you
Completed
|

A Study of LY3127804 with Ramucirumab in Participants with Advanced Solid Tumors

Enter your postal code
to see sites near you
Completed
|

A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Enzalutamide and LY3023414 in Men with Prostate Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus

Enter your postal code
to see sites near you
Completed
|

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Enter your postal code
to see sites near you
Completed
|

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Enter your postal code
to see sites near you
Completed
|

A Study of Ixekizumab in Participants with Plaque Psoriasis

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Enter your postal code
to see sites near you
Completed
|

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

Enter your postal code
to see sites near you
Completed
|

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

Enter your postal code
to see sites near you
Completed
|

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Completed
|

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Mirikizumab in Participants With Plaque Psoriasis

Enter your postal code
to see sites near you
Completed
|

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Enter your postal code
to see sites near you
Completed
|

A Study Comparing LY900014 to Insulin Lispro in Adults With Type 1 Diabetes Using Insulin Pump Therapy

Enter your postal code
to see sites near you
Completed
|

A Study of Lasmiditan in Participants With Migraine

Enter your postal code
to see sites near you
Completed
|

A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy

Enter your postal code
to see sites near you
Completed
|

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Enter your postal code
to see sites near you
Completed
|

A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

Enter your postal code
to see sites near you
Completed
|

A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma that has Spread to the Brain

Enter your postal code
to see sites near you
Completed
|

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Enter your postal code
to see sites near you
Completed
|

A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Enter your postal code
to see sites near you
Completed
|

A Study of Necitumumab (LY3012211) and Abemaciclib (LY2835219) in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

Enter your postal code
to see sites near you
Completed
|

A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer

Enter your postal code
to see sites near you
Completed
|

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

Enter your postal code
to see sites near you
Completed
|

A Safety Study of LY2951742 in Participants With Migraine, With or Without Aura

Enter your postal code
to see sites near you
Completed
|

A Study of LY3039478 in Participants with Advanced Cancer

Enter your postal code
to see sites near you
Completed
|

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

Enter your postal code
to see sites near you
Completed
|

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (SPIRIT P3)

Enter your postal code
to see sites near you
Completed
|

A Study of LY2157299 in Participants With Hepatocellular Carcinoma

Enter your postal code
to see sites near you
Completed
|

A Study of LY3041658 in Participants With Skin Diseases

Enter your postal code
to see sites near you
Completed
|

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Enter your postal code
to see sites near you
Completed
|

A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Enter your postal code
to see sites near you
Completed
|

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Enter your postal code
to see sites near you
Completed
|

A Study of LY2951742 in Participants With Episodic Cluster Headache

Enter your postal code
to see sites near you
Completed
|

A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated with Idiopathic Parkinson’s Disease (PD) or Dementia with Lewy Bodies (DLB) (PRESENCE)

Enter your postal code
to see sites near you
Terminated
|

A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA

Enter your postal code
to see sites near you
Terminated
|

A Study of LY2599666 in Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Enter your postal code
to see sites near you
Terminated
|

A Study of Prexasertib (LY2606368) with Chemotherapy and Radiation in Participants with Head and Neck Cancer

Enter your postal code
to see sites near you
Terminated
|

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)

Enter your postal code
to see sites near you
Terminated
|

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Participants With Early Alzheimer's Disease (AMARANTH)

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3415244 in Participants With Advanced Solid Tumors

Enter your postal code
to see sites near you
Terminated
|

A Study of Lanabecestat (LY3314814) in Participants With Early Alzheimer's Disease Dementia

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3127804 in Participants With COVID-19

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3435151 in Participants With Solid Tumors

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NAVIGATE-AD)

Enter your postal code
to see sites near you
Terminated
|

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3337641 in Participants With Rheumatoid Arthritis (RAjuvenate)

Enter your postal code
to see sites near you
Terminated
|

A Study of U-500 Insulin (Humulin LY041001) in Participants With Type 2 Diabetes

Enter your postal code
to see sites near you
Terminated
|

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Enter your postal code
to see sites near you
Terminated
|

A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation

Enter your postal code
to see sites near you